We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+4.35%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$1.06B
AUM Growth
-$4.21M
Cap. Flow
-$36.2M
Cap. Flow %
-3.4%
Top 10 Hldgs %
45.51%
Holding
2,874
New
227
Increased
1,384
Reduced
630
Closed
115

Top Sells

Rank Stock Value
1
OCSL icon
Oaktree Specialty Lending
OCSL
+$12.7M
2
NVDA icon
NVIDIA
NVDA
+$6.29M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$3.66M
4
AAPL icon
Apple
AAPL
+$3.19M
5
AVGO icon
Broadcom
AVGO
+$2.17M

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Financials 12.25%
3 Healthcare 6.29%
4 Communication Services 4.39%
5 Consumer Discretionary 3.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
J icon
1151
Jacobs Solutions
J
$17B
$23.6K ﹤0.01%
204
+41
+25% +$4.81K
CRL icon
1152
Charles River Laboratories
CRL
$12.8B
$23.6K ﹤0.01%
114
DOCU
1153
DocuSign
DOCU
$11.5B
$23.5K ﹤0.01%
440
+14
+3% +$790
FCPT icon
1154
Four Corners Property Trust
FCPT
$2.75B
$23.5K ﹤0.01%
952
-7
-0.7% -$169
DEA
1155
Easterly Government Properties
DEA
$1.18B
$23.5K ﹤0.01%
758
+376
+98% +$11.1K
SLAB icon
1156
Silicon Laboratories
SLAB
$7.23B
$23.5K ﹤0.01%
212
-32
-13% -$3.95K
BRKR icon
1157
Bruker
BRKR
$8.14B
$23.4K ﹤0.01%
366
+5
+1% +$376
ONB icon
1158
Old National Bancorp
ONB
$10.2B
$23.2K ﹤0.01%
1,350
+348
+35% +$5.78K
ENVX icon
1159
Enovix
ENVX
$1.03B
$23.2K ﹤0.01%
1,713
+498
+41% +$4.16K
BRFS
1160
DELISTED
BRF SA
BRFS
$23.1K ﹤0.01%
5,673
+233
+4% +$819
BWXT icon
1161
BWX Technologies
BWXT
$15.6B
$23.1K ﹤0.01%
243
+29
+14% +$2.69K
DTD icon
1162
WisdomTree US Total Dividend Fund
DTD
$1.69B
$22.9K ﹤0.01%
324
ITCI
1163
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$22.9K ﹤0.01%
335
-53
-14% -$3.68K
MARA icon
1164
Marathon Digital Holdings
MARA
$3.9B
$22.9K ﹤0.01%
1,155
+176
+18% +$3.34K
AGCO icon
1165
AGCO
AGCO
$7.2B
$22.9K ﹤0.01%
234
+99
+73% +$11K
BMRN icon
1166
BioMarin Pharmaceuticals
BMRN
$12.4B
$22.9K ﹤0.01%
278
-36
-11% -$3K
EAT icon
1167
Brinker International
EAT
$9.66B
$22.9K ﹤0.01%
316
+117
+59% +$6.97K
MOR
1168
DELISTED
MorphoSys AG American Depositary Shares
MOR
$22.9K ﹤0.01%
1,256
+8
+0.6% +$145
CWEN icon
1169
Clearway Energy Class C
CWEN
$6.7B
$22.8K ﹤0.01%
924
+237
+34% +$5.99K
RCI icon
1170
Rogers Communications
RCI
$18.6B
$22.8K ﹤0.01%
616
-354
-36% -$13.7K
ALX
1171
Alexander's
ALX
$1.41B
$22.7K ﹤0.01%
101
ICL icon
1172
ICL Group
ICL
$6.85B
$22.7K ﹤0.01%
5,306
-2,303
-30% -$10.8K
NICE icon
1173
Nice
NICE
$5.97B
$22.7K ﹤0.01%
132
-67
-34% -$13.8K
LSXMA
1174
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$22.6K ﹤0.01%
1,020
BIDU icon
1175
Baidu
BIDU
$37.2B
$22.6K ﹤0.01%
261
-192
-42% -$19.3K

Similar funds

Lindbrook Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Lindbrook Capital held 2,874 positions worth $1.06B, down 0.39% from $1.07B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital withdrew a net $36.2M in Q2 2024, closing 115 positions and reducing 630 holdings. Its most notable exit was ProShares UltraPro QQQ, an estimated $1.24M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Lindbrook Capital opened a new position in Nuveen ESG Small-Cap ETF worth $323K.

  • Lindbrook Capital's largest Q2 2024 buy was Nuveen ESG Small-Cap ETF: 8,216 shares worth $323K.
  • Lindbrook Capital added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $3.36M increase.
  • Lindbrook Capital's biggest Q2 2024 reduction was Oaktree Specialty Lending, cutting an estimated $12.7M.
  • Lindbrook Capital fully exited ProShares UltraPro QQQ in Q2 2024, selling an estimated $1.24M.
  • Lindbrook Capital's ten largest holdings make up 46% of its $1.06B portfolio in Q2 2024.
  • Lindbrook Capital opened 227 new positions and closed 115 in Q2 2024.
  • Lindbrook Capital's portfolio value fell 0.39% quarter-over-quarter to $1.06B.

Based on Lindbrook Capital's 13F filing for Q2 2024, filed 31 Jul 2024.